Valuation: GC Genome Corporation

Market Cap 11TCr 7.05Cr 6.18Cr 5.73Cr 5.27Cr 9.96Cr 674.55Cr 10Cr 68Cr 27Cr 331.25Cr 26Cr 26Cr 1.14TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 4.58Cr 30.7T 26.93T 24.94T 22.95T 43.4T 29.38L 44.25T 3L 1L 14.43L 1L 1L 49.83L EV / Sales 2026 *
1.18x
EV / Sales 2027 * 0.75x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-6.71%
1 week-8.44%
Current month-9.46%
1 month-16.51%
3 months-40.51%
6 months-32.98%
Current year-34.75%
1 week 4,300
Extreme 4300
4,900
1 month 4,225
Extreme 4225
5,710
Current year 4,225
Extreme 4225
9,520
1 year 4,225
Extreme 4225
9,520
3 years 4,225
Extreme 4225
15,180
5 years 4,225
Extreme 4225
15,180
10 years 4,225
Extreme 4225
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap.
17/25/17Free

Chief Executive Officer

1,69,285 -
17/25/17Free 1,38,250 -
Change 5-day change 1-year change 3-year change Capi.($)
-6.71%-8.44%-51.74% - 7.05Cr
+1.09%-3.84%+70.10%+437.29% 3.91TCr
-0.05%-2.71%+10.84%+30.67% 2.27TCr
+2.29%-2.06%-21.43%-40.04% 717.49Cr
-3.49%-8.14%+14.11%+106.96% 497.83Cr
+0.93%+3.58%+20.17%+47.76% 301.11Cr
-2.73%-7.32%-22.66%+818.71% 189.56Cr
-1.17%+4.12%+33.47%-21.11% 182.23Cr
0.00%-6.93%+94.35%-18.81% 183.73Cr
-1.64%+3.19%+27.97%+4.06% 171.23Cr
Average -1.15%-2.48%+17.52%+151.72% 842.72Cr
Weighted average by Cap. +0.39%-3.23%+37.95%+233.50%

Financials

2026 *2027 *
Net sales 3.9TCr 2.61Cr 2.29Cr 2.12Cr 1.95Cr 3.69Cr 249.96Cr 3.76Cr 25Cr 9.92Cr 122.75Cr 9.81Cr 9.59Cr 423.92Cr 4.88TCr 3.27Cr 2.87Cr 2.65Cr 2.44Cr 4.62Cr 312.77Cr 4.71Cr 32Cr 12Cr 153.59Cr 12Cr 12Cr 530.44Cr
Net income - -
Net Debt -5.94TCr -3.98Cr -3.49Cr -3.23Cr -2.97Cr -5.62Cr -380.71Cr -5.73Cr -39Cr -15Cr -186.96Cr -15Cr -15Cr -645.66Cr -6.88TCr -4.61Cr -4.04Cr -3.74Cr -3.44Cr -6.51Cr -440.96Cr -6.64Cr -45Cr -17Cr -216.54Cr -17Cr -17Cr -747.83Cr
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
13/26/13 ₩4,450.00 -6.71% 63,035
10/26/10 ₩4,770.00 +5.41% 56,967
09/26/09 ₩4,525.00 -1.95% 1,51,494
08/26/08 ₩4,615.00 -3.35% 84,948
07/26/07 ₩4,775.00 -1.75% 1,17,949

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock